Rocket Lab Corp
Business
Rocket Lab is an end-to-end space company providing orbital and suborbital launch services, spacecraft design and manufacturing, spacecraft components, and on-orbit management solutions. The company operates the Electron small-lift launch vehicle and is developing the medium-lift Neutron vehicle, complemented by a family of configurable spacecraft including the Photon platform. Rocket Lab serves commercial, civil government, and defense customers globally through private launch complexes in New Zealand and Virginia, plus manufacturing facilities across the United States, New Zealand, and Canada.
Summary from 10-K filed 2026-02-26
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenues | 602 | 436 | 245 | 211 | 62 | |
| Total cost of revenues | 395 | 320 | 193 | 192 | 64 | |
| Gross profit | 207 | 116 | 51 | 19 | −2 | |
| Research and development, net | 271 | 174 | 119 | 65 | 42 | |
| Selling, general and administrative | 165 | 132 | 110 | 89 | 58 | |
| Total operating expenses | 436 | 306 | 229 | 154 | 100 | |
| Operating loss | −229 | −190 | −178 | −135 | −102 | |
| Interest expense | −26 | −26 | −18 | — | — | |
| Interest income | 26 | 22 | 13 | — | — | |
| Loss on foreign exchange | −463,000 | −87,000 | −470,000 | −4 | −567,000 | |
| Other income, net | 4 | 4 | 4 | 1 | −798,000 | |
| Total other income (expense), net | 3 | 390,000 | −1 | 2 | −23 | |
| Loss before income taxes | −226 | −189 | −179 | −133 | −125 | |
| Benefit (provision) for income taxes | 28 | −764,000 | −4 | −3 | 8 | |
| Net loss | −198 | −190 | −183 | −136 | −117 | |
| Foreign currency translation gain (loss) | 624,000 | −5 | −93,000 | 600,000 | 253,000 | |
| Unrealized gain on available-for-sale marketable securities | 217,000 | 455,000 | 494,000 | −772,000 | 0 | |
| Comprehensive loss | −197 | −195 | −182 | −136 | −117 | |
| Basic (in dollars per share) | −0.37 | −0.38 | −0.38 | −0.29 | −0.56 | |
| Diluted (in dollars per share) | −0.37 | −0.38 | −0.38 | −0.29 | −0.56 | |
| Basic (in shares) | 531 | 496 | 482 | 466 | 210 | |
| Diluted (in shares) | 531 | 496 | 482 | 466 | 210 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 829 | 271 | 163 | 243 | 691 | |
| Marketable securities, current | 188 | 148 | 82 | 229 | 0 | |
| Accounts receivable, net | 39 | 36 | 35 | 37 | 14 | |
| Contract assets | 62 | 63 | 13 | 9 | 2 | |
| Inventories | 158 | 119 | 108 | 92 | 48 | |
| Prepaids and other current assets | 90 | 55 | 67 | 52 | 19 | |
| Total current assets | 1,366 | 693 | 477 | 662 | 775 | |
| Property, plant and equipment, net | 319 | 195 | 145 | 102 | 65 | |
| Intangible assets, net | 225 | 59 | 68 | 80 | 57 | |
| Goodwill | 206 | 71 | 71 | 71 | 43 | |
| Right-of-use assets - operating leases | 90 | 54 | 59 | 35 | 28 | |
| Right-of-use assets - finance leases | 14 | 14 | 15 | 16 | 0 | |
| Marketable securities, non-current | 82 | 61 | 79 | 9 | 0 | |
| Restricted cash | 5 | 4 | 4 | 3 | 1 | |
| Deferred income tax assets, net | 2 | 3 | 4 | 4 | 6 | |
| Other non-current assets | 16 | 31 | 19 | 7 | 5 | |
| Total assets | 2,324 | 1,184 | 941 | 989 | 981 | |
| Trade payables | 73 | 53 | 29 | 12 | 3 | |
| Accrued expenses | 19 | 19 | 6 | 9 | 11 | |
| Employee benefits payable | 26 | 21 | 16 | 9 | 8 | |
| Contract liabilities | 195 | 216 | 139 | 108 | 60 | |
| Current installments of long-term borrowings | 0 | 12 | 18 | 3 | 3 | |
| Other current liabilities | 21 | 18 | 15 | 22 | 11 | |
| Total current liabilities | 334 | 340 | 223 | 163 | 96 | |
| Convertible senior notes, net | 152 | 345 | 0 | — | — | |
| Long-term borrowings, net, excluding current installments | 2 | 44 | 88 | 100 | 97 | |
| Non-current operating lease liabilities | 85 | 52 | 56 | 34 | 28 | |
| Non-current finance lease liabilities | 15 | 15 | 15 | 16 | 0 | |
| Deferred tax liabilities | 1 | 891,000 | 426,000 | 95,000 | 466,000 | |
| Other non-current liabilities | 13 | 5 | 4 | 3 | 2 | |
| Total liabilities | 603 | 802 | 387 | 316 | 282 | |
| COMMITMENTS AND CONTINGENCIES (Note 17) | — | — | — | — | — | |
| Preferred stock, $0.0001 par value; authorized shares: 100,000,000; issued and outstanding shares: 45,951,250 and 0 at December 31, 2025 and December 31, 2024, respectively | 5,000 | 0 | 0 | — | — | |
| Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued shares: 589,525,802 and 504,453,785 at December 31, 2025 and December 31, 2024, respectively; outstanding shares 543,574,552 and 504,453,785 at December 31, 2025 and December 31, 2024, respectively | 54,000 | 50,000 | 49,000 | 48,000 | 45,000 | |
| Treasury stock, at cost; shares: 45,951,250 and 0 at December 31, 2025 and December 31, 2024, respectively | 0 | 0 | — | — | — | |
| Additional paid-in capital | 2,736 | 1,199 | 1,176 | 1,113 | 1,002 | |
| Accumulated deficit | −1,012 | −814 | −624 | −441 | −305 | |
| Accumulated other comprehensive loss | −2 | −3 | 2 | 1 | 1 | |
| Total stockholders equity | 1,722 | 382 | 555 | 673 | 698 | |
| Total liabilities and stockholders equity | 2,324 | 1,184 | 941 | 989 | 981 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net loss | −198 | −190 | −183 | −136 | −117 | |
| Depreciation and amortization | 44 | 34 | 30 | 30 | 11 | |
| Stock-based compensation expense | 71 | 57 | 53 | 56 | 33 | |
| Loss (gain) on disposal of assets | 3 | −3 | −111,000 | 923,000 | — | |
| Loss on extinguishment of long-term debt | 6 | 1 | 2 | 0 | 496,000 | |
| Amortization of debt issuance costs and discount | 3 | 3 | 3 | 3 | 2 | |
| Noncash lease expense | 8 | 6 | 6 | 3 | — | |
| Change in the fair value of contingent consideration | −11 | −218,000 | 1 | 0 | 0 | |
| Accretion of marketable securities purchased at a discount | −2 | −3 | −5 | −1 | 0 | |
| Deferred income taxes | −31 | 599,000 | 708,000 | −576,000 | −10 | |
| Accounts receivable, net | 667,000 | −1 | 1 | −9 | −8 | |
| Contract assets | 2 | −50 | −4 | −8 | 2 | |
| Inventories | −40 | −12 | −16 | −26 | −12 | |
| Prepaids and other current assets | −15 | 8 | −15 | −15 | −11 | |
| Other non-current assets | 16 | −13 | −11 | −7 | −5 | |
| Trade payables | 10 | 25 | 16 | −2 | −5 | |
| Accrued expenses | −2 | 9 | −3 | −4 | 3 | |
| Employee benefits payable | 2 | 5 | 5 | 2 | −326,000 | |
| Contract liabilities | −22 | 77 | 31 | 23 | 28 | |
| Other current liabilities | 849,000 | 3 | −8 | 1 | 838,000 | |
| Non-current lease liabilities | −12 | −6 | −5 | −4 | −2 | |
| Other non-current liabilities | 223,000 | 2 | 227,000 | 668,000 | 370,000 | |
| Net cash used in operating activities | −166 | −49 | −99 | −107 | −72 | |
| Purchases of property, equipment and software | −156 | −67 | −55 | −42 | −26 | |
| Proceeds on disposal of assets, net | 397,000 | 13 | 4 | 0 | — | |
| Cash paid for business combinations and asset acquisitions, net of acquired cash | −132 | 0 | −19 | −66 | −66 | |
| Purchases of marketable securities | −275 | −162 | −207 | −260 | 0 | |
| Maturities of marketable securities | 213 | 116 | 269 | 22 | — | |
| Sale of marketable securities | 3 | 2 | 20 | 0 | 0 | |
| Net cash (used in) provided by investing activities | −347 | −98 | 12 | −346 | −92 | |
| Proceeds from ATM Equity Offerings | 1,146 | 0 | 0 | — | — | |
| Issuance costs related to ATM Equity Offerings | −27 | 0 | 0 | — | — | |
| Proceeds from the exercise of stock options | 3 | 4 | 2 | 4 | 3 | |
| Proceeds from Employee Stock Purchase Plan | 11 | 6 | 5 | 4 | 0 | |
| Proceeds from sale of employees restricted stock units to cover taxes | 113 | 35 | 16 | 31 | 0 | |
| Minimum tax withholding paid on behalf of employees for restricted stock units | −113 | −35 | −16 | −31 | 0 | |
| Payment of contingent consideration | 0 | 0 | −1 | −6 | 0 | |
| Finance lease principal payments | −268,000 | −329,000 | −336,000 | −271,000 | 0 | |
| Purchase of capped calls related to issuance of convertible senior notes | 0 | −43 | 0 | 0 | — | |
| Proceeds from issuance of convertible senior notes | 0 | 355 | 0 | 0 | — | |
| Proceeds from secured term loan | 27 | 0 | 110 | 0 | 99 | |
| Repayments on secured term loans | −88 | −52 | −108 | 0 | 0 | |
| Payment of debt issuance costs | −278,000 | −12 | −1 | 0 | 0 | |
| Net cash provided by financing activities | 1,071 | 257 | 7 | 2 | 800 | |
| Effect of exchange rate changes on cash and cash equivalents | −110,000 | −597,000 | 43,000 | 4 | 2 | |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 558 | 109 | −79 | −446 | 638 | |
| Cash paid for interest | 25 | 16 | 16 | 11 | 4 | |
| Cash paid for income taxes | 854,000 | 269,000 | 769,000 | 3 | −2 | |
| Unpaid purchases of property, equipment and software | 19 | 8 | 3 | 2 | 938,000 | |
| Right-of-use assets obtained in exchange for new operating lease liabilities | 39 | 3 | 30 | 9 | 4 | |
| Early termination of right-of-use assets | 0 | 0 | 664,000 | 0 | 0 | |
| Issuance of common stock for payment of accrued bonus | 2 | 2 | 0 | 1 | 0 | |
| Issuance of common stock warrants in connection with Loan Agreement | 0 | 0 | 3 | 0 | 0 | |
| Issuance of common stock in connection with acquisition, at fair value | 138 | 838,000 | 2 | — | — | |
| Contingent consideration assumed at acquisition | 18 | 0 | 0 | — | — | |
| Accrued issuance costs in connection with Loan Agreement | 0 | 0 | 641,000 | 0 | 0 | |
| Accrued issuance costs in connection with ATM Equity Offerings | 214,000 | 0 | 0 | — | — | |
| Convertible senior notes, net and accrued interest settled by issuance of common stock | 197 | 0 | 0 | — | — | |
| Payable to seller in connection with business combination | 578,000 | 0 | 0 | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Rocket Lab Corp's CIK number?
Rocket Lab Corp's SEC CIK number is 0001819994 (1819994). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Rocket Lab Corp's SEC filings?
All of Rocket Lab Corp's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Rocket Lab Corp last report earnings?
Rocket Lab Corp (RKLB) most recently filed an earnings 8-K with the SEC on May 7, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001819994-26-000027). This is Rocket Lab Corp's most recent earnings filing of record — not a forecast of its next earnings date.
What is Rocket Lab Corp's most recent earnings 8-K?
Rocket Lab Corp's latest earnings 8-K (Item 2.02) was filed May 7, 2026 under accession 0001819994-26-000027. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Rocket Lab Corp's latest earnings 8-K →
Look up any company's CIK number →